Not Signed In -
Memantine |
Namenda |
Clinical Trial: Memantine in Patients with Chronic Glaucoma
This study is no longer recruiting patients.
|
Purpose
Randomized double-masked clinical trial of memantine in patients with glaucoma
| Condition | Intervention | Phase |
|---|---|---|
| Open-Angle Glaucoma | Drug: memantine | Phase III |
MedlinePlus related topics: Glaucoma
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: Progression of glaucoma
Expected Total Enrollment: 1000
Expected Total Enrollment: 1000
Eligibility
Ages Eligible for Study: 18 Years - 80 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
glaucoma damage on examination of visual field and optic disc; good visual acuity (with glasses if needed)
More Information
Study ID Numbers: 192944-004
Last Updated: September 1, 2005
Record first received: August 31, 2005
ClinicalTrials.gov Identifier: NCT00141882
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 1, 2005
Record first received: August 31, 2005
ClinicalTrials.gov Identifier: NCT00141882
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
